OLD Category: methods

Application of NanoString technologies in companion diagnostic development

• Eastel JM et al.,

Immune signature profiling identified prognostic factors for gastric cancer

• Yang W et al.,

Epigenetically regulated imprinted gene expression associated with IVF and infertility: possible influence of prenatal stress and depression

• Litzky JF, Marsit CJ

A new normalization for Nanostring nCounter gene expression data

• Molania R et al.,

Differential genomic and transcriptomic events associated with high-grade transformation of Chronic Lymphocytic Leukemia

• Klintman J et al.,

Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres

• Kaur K et al.,

Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy

• Gubbiotti MA, Buraschi S, Kapoor A, Iozzo RV

Latent periodic process inference from single-cell RNA-seq data

• Liang S et al.,

Genomic testing in myeloid malignancy

• Docking TR et al.,Int J Lab Hematol.

Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip

• Delmonico L et al.,

The tech for the next decade: promises andchallenges in genome biology

• Hajirasouliha I, Tilgner HU.

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

• Pallocca M et al.,